Clinical Trial Update: Heart Rate Response to Regadenoson and Sudden Cardiac Death [NA]

View source ↗

Summary

Clinical trial update on heart rate response to regadenoson and its relation to sudden cardiac death in patients with left ventricular systolic dysfunction; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Systolic Dysfunction
• Sudden Cardiac Death

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Left Ventricular Systolic Dysfunction, Sudden Cardiac Death | NA | Status: COMPLETED | Results posted: 2022-04-04